Early circulating tumor DNA dynamics and clonal selection with palbociclib and fulvestrant for breast cancer

Early circulating tumor DNA dynamics and clonal selection with palbociclib and fulvestrant for breast cancer

Circulating tumor DNA (ctDNA) may provide a prediction of treatment response, but could be impacted by tumor heterogeneity. Here, the authors investigate ctDNA in CDK4/6 inhibitor treatment in advanced breast cancer, finding ctDNA levels predict progression-free survival and anticipate clonal select...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ben O’Leary, Sarah Hrebien, James P. Morden, Matthew Beaney, Charlotte Fribbens, Xin Huang, Yuan Liu, Cynthia Huang Bartlett, Maria Koehler, Massimo Cristofanilli, Isaac Garcia-Murillas, Judith M. Bliss, Nicholas C. Turner
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2018
Materias:
Science
Q
Acceso en línea:https://doaj.org/article/fe55104b6a3946c08222bef99156c284
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/fe55104b6a3946c08222bef99156c284

Ejemplares similares